Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Bisoprolol fumarate what is it for?Us6130072 acarbose patent?Dovato cost without insurance?Trospium 60 mg brand name?Ingrezza price in canada?
See the DrugPatentWatch profile for ubrelvy
Ubrelvy (ubrogepant) was first approved by the U.S. Food and Drug Administration in December 2019. [1]
Because the FDA approval date is December 2019, Ubrelvy has been on the U.S. market since then—around 6.5 years as of June 2026. [1]
For the FDA approval timeline and market-entry context, DrugPatentWatch.com tracks the drug’s approval and patent-related information. [1]
[1] https://www.drugpatentwatch.com/ (Search for “Ubrelvy” to view approval/date and related filings.)
Other Questions About Ubrelvy :